Compass Therapeutics Investor Presentation Deck
May 2022, 36 slides
  1. Compass Therapeutics
  2. Related Decks
  3. Investor Presentation Decks
compass therapeutics presentation may | Compass Therapeutics
disclaimer | Compass Therapeutics
advanced biliary track cancers professor and director emeritus the west university cancer institute | Compass Therapeutics
of | Compass Therapeutics
epidemiology cases deaths us lifetime risk highest in chile and countries increase in incidence over last decades risk factors inherited liver flukes chronic liver or biliary inflammation obesity tobacco use | Compass Therapeutics
presentation jaundice yellow eyes itching dark urine light colored stool loss of appetite and weight loss abdominal pain night sweats found incidentally at the time of gall bladder surgery | Compass Therapeutics
| Compass Therapeutics
| Compass Therapeutics
patient enrollment randomization and treatment | Compass Therapeutics
outcomes | Compass Therapeutics
gastrointestinal a phase randomized double blind placebo controlled study of in combination with plus in patients with advanced biliary tract cancer topaz | Compass Therapeutics
topaz study design | Compass Therapeutics
primary | Compass Therapeutics
secondary | Compass Therapeutics
secondary tumor response | Compass Therapeutics
survival after line therapy in and topaz median post progression was about months | Compass Therapeutics
unmet need for second line therapies for | Compass Therapeutics
treatment paradigm for | Compass Therapeutics
targeted therapy in instability fusion fusion eligible for current therapies | Compass Therapeutics
| Compass Therapeutics
| Compass Therapeutics
median survival | Compass Therapeutics
chemotherapy in | Compass Therapeutics
there clearly are unmet needs in managing | Compass Therapeutics
update executive summary | Compass Therapeutics
phase combination study with | Compass Therapeutics
phase combination study waterfall plot | Compass Therapeutics
phase combination safety data | Compass Therapeutics
phase combination study plus | Compass Therapeutics
phase combination study status | Compass Therapeutics
phase patient and demographics | Compass Therapeutics
phase waterfall a | Compass Therapeutics
swimmer plot median time on study months | Compass Therapeutics
safety data treatment related grade adverse events | Compass Therapeutics
next steps | Compass Therapeutics
interim phase study summary | Compass Therapeutics
See More
Compass Therapeutics
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Clinical trial
Recent decks by Compass Therapeutics
Investor Presentation
May 2023
Investor Presentation
February 2023
Investor Presentation
January 2023
Investor Presentation
May 2022
See all presentations by Compass Therapeutics (6 decks)
Related decks
Nuvalent
Investor Presentation
April 2024
RayzeBio
IPO
September 2023
Genelux
Investor Presentation
July 2023
Exscientia
Investor Presentation
October 2023
Mink Therapeutics
IPO
October 2021
Genelux
Investor Presentation
February 2024
Nuvalent
Investor Presentation
January 2024
Context Therapeutics
Investor Presentation
September 2022
Recent decks by Compass Therapeutics
See all presentations (6 decks)
Investor Presentation
May 2023
Investor Presentation
February 2023
Investor Presentation
January 2023
Investor Presentation
May 2022
Nuvalent
Investor Presentation
April 2024
RayzeBio
IPO
September 2023
Genelux
Investor Presentation
July 2023
Exscientia
Investor Presentation
October 2023
Mink Therapeutics
IPO
October 2021
Genelux
Investor Presentation
February 2024
Nuvalent
Investor Presentation
January 2024
Context Therapeutics
Investor Presentation
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io